Updated Management of Ulcerative Colitis

Ulcerative Colitis (UC) is a chronic disorder of Inflammatory Bowel Disease (IBD) which showed pathological changes of mucosa (symmetrical, diffuse) that involving rectum and may be extended to proximal colon. In general, target of the treatment quite indistinguishable to Crohn’s Disease (CD), such as improving quality of life, treating the acute condition, maintaining remission status, preventing complications, and achieving adequate nutritional status. Nowadays, there are so many therapeutic agents which were more effective than previous drugs. Another reason we should have left prior medicine is the safety of newer agents are promising. Today’s technology advances make gastroenterologist easier to give more treatment choice to every spectrum of ulcerative colitis. This review aims to provide an updated overview of ulcerative colitis management.

Authors

Institutions

Publication Details

Journal
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy
Published
2025-08-15
DOI
https://doi.org/10.24871/2622025160-167
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Updated Management of Ulcerative Colitis

Achmad Fauzi, Muhamad Reza Prabowo
The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy
Inflammatory Bowel Disease
article

Updated Management of Ulcerative Colitis

Achmad Fauzi, Muhamad Reza Prabowo
article en

Abstract

Ulcerative Colitis (UC) is a chronic disorder of Inflammatory Bowel Disease (IBD) which showed pathological changes of mucosa (symmetrical, diffuse) that involving rectum and may be extended to proximal colon. In general, target of the treatment quite indistinguishable to Crohn’s Disease (CD), such as improving quality of life, treating the acute condition, maintaining remission status, preventing complications, and achieving adequate nutritional status. Nowadays, there are so many therapeutic agents which were more effective than previous drugs. Another reason we should have left prior medicine is the safety of newer agents are promising. Today’s technology advances make gastroenterologist easier to give more treatment choice to every spectrum of ulcerative colitis. This review aims to provide an updated overview of ulcerative colitis management.

The Indonesian Journal of Gastroenterology Hepatology and Digestive EndoscopyVol. 26(2)
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID)
Openalex Percentile: Top 76%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.